Healthcare Bullish Stocks: Dyax Corp. (NASDAQ:DYAX), Incyte Corporation (NASDAQ:INCY), ISIS Pharmaceuticals (NASDAQ:ISIS), NPS Pharmaceuticals (NASDAQ:NPSP)



Dyax Corp. (NASDAQ:DYAX) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. Dyax Corp. (NASDAQ:DYAX) currently has a Zacks Rank #3 (Hold). Dyax Corp. (NASDAQ:DYAX) stock performance was 5.90% in last session and finished the day at $8.98. Traded volume was 3.39million shares in the last session and the average volume of the stock remained 1.42million shares. The beta of the stock remained 1.35. Dyax Corp. (NASDAQ:DYAX) insider ownership is 0.60%.

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Incyte Corporation (NASDAQ:INCY) was identified as having a larger market cap than the smaller end of the S&P 500, for example Molson Coors Brewing Co. (TAP_), according to The Online Investor. Incyte Corporation (NASDAQ:INCY) rose 7.17 percent to $53.52 Monday on volume of 2.25million shares. The intra-day range of the stock was $50.27 to $53.81. Incyte Corporation (NASDAQ:INCY) has a market capitalization of $8.86billion.

Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) announced the final results from its Phase 2 study of ISIS-APOCIIIRx in patients with high to severely high triglycerides on stable doses of fibrates. In this study, patients treated with ISIS-APOCIIIRx achieved average reductions of up to 71 percent in apolipoprotein C-III (apoC-III) and up to 64 percent in triglycerides, and average increases of up to 52 percent in high-density lipoprotein cholesterol (HDL-C), the ‘good’ cholesterol. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)’s stock on Mar 31, 2014 reported a increase of 8.84% to the closing price of $43.21. Its fifty two weeks range is $15.92 -$62.66. The total market capitalization recorded $5.07billion. The overall volume in the last trading session was 2.32million shares. In its share capital, ISIS has 117.27million outstanding shares.

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the 13(th) Annual Needham Healthcare Conference in New York on Tuesday, April 8, 2014 at 8:00 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded. On Monday, shares of NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) advanced 5.87% to close the day at $29.93. Company return on investment (ROI) is -0.70% and its monthly performance is recorded as -14.44%. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) quarterly revenue growth is 0.88%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone